EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC 4.0

Two‐year effect of semaglutide 2.4 mg on control of eating in adults with overweight/obesity: STEP 5

Sean Wharton iD, Rachel L Batterham, Meena Bhatta, Silvio Buscemi iD, Louise N Christensen, Juan P Frias, Esteban Jódar, Kristian Kandler, Georgia Rigas, Thomas A Wadden iD, W Timothy Garvey iD

Obesity · 2023-03 · 31 (3) · 703-715

DOI: 10.1002/oby.23673 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Obesity, online erschienen am 18.01.2023. Verfasst von Sean Wharton und 10 weiteren Autor:innen. Beteiligte Einrichtung: York University, McMaster University, and Wharton Weight Management Clinic, Burlington, Ontario, Canada. Hauptthemen laut MEDLINE: Overweight, Eating. Die Arbeit wurde bisher 131-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

This study evaluated the effect of once‐weekly semaglutide 2.4 mg on 2‐year control of eating.

Methods

In STEP 5, adults with overweight/obesity were randomized 1:1 to semaglutide 2.4 mg or placebo, plus lifestyle modification, for 104 weeks. A 19‐item Control of Eating Questionnaire was administered at weeks 0, 20, 52, and 104 in a subgroup of participants. P values were not controlled for multiplicity.

Results

In participants completing the Control of Eating Questionnaire (semaglutide, n = 88; placebo, n = 86), mean body weight changes were −14.8% (semaglutide) and −2.4% (placebo). Scores significantly improved with semaglutide versus placebo for Craving Control and Craving for Savory domains at weeks 20, 52, and 104 ( p < 0.01); for Positive Mood and Craving for Sweet domains at weeks 20 and 52 ( p < 0.05); and for hunger and fullness at week 20 ( p < 0.001). Improvements in craving domain scores were positively correlated with reductions in body weight from baseline to week 104 with semaglutide. At 104 weeks, scores for desire to eat salty and spicy food, cravings for dairy and starchy foods, difficulty in resisting cravings, and control of eating were significantly reduced with semaglutide versus placebo (all p < 0.05).

Conclusions

In adults with overweight/obesity, semaglutide 2.4 mg improved short‐ and longer‐term control of eating associated with substantial weight loss. image

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OverweightEatingAdultHumansObesityBody WeightCravingSemaglutide

Substanzen

Semaglutide

Autor:innen und Institutionen

  • York University, McMaster University, and Wharton Weight Management Clinic, Burlington, Ontario, Canada.
  • Division of Medicine, University College London Centre for Obesity Research, University College London, London, UK.
  • National Institute of Health Research, University College London Hospital Biomedical Research Centre, London, UK.
  • Centre for Weight Management and Metabolic Surgery, University College London Hospital, London, UK.
  • Novo Nordisk A/S, Søborg, Denmark.
  • Unit of Clinical Nutrition, Policlinico University Hospital, Palermo, Italy.

ORCID-Profile: Sean Wharton, Silvio Buscemi, Thomas A Wadden, W Timothy Garvey

Zitieren

APA

Wharton, S., Batterham, R. L., Bhatta, M., Buscemi, S., Christensen, L. N., Frias, J. P., Jódar, E., Kandler, K., Rigas, G., Wadden, T. A., & Garvey, W. T. (2023). Two‐year effect of semaglutide 2.4 mg on control of eating in adults with overweight/obesity: STEP 5. Obesity, 31(3), 703-715. https://doi.org/10.1002/oby.23673

Vancouver

Wharton S, Batterham RL, Bhatta M, Buscemi S, Christensen LN, Frias JP, et al. Two‐year effect of semaglutide 2.4 mg on control of eating in adults with overweight/obesity: STEP 5. Obesity. 2023;31(3):703-715. doi:10.1002/oby.23673

BibTeX
@article{Wharton2023,
  author = {Wharton, Sean and Batterham, Rachel L and Bhatta, Meena and Buscemi, Silvio and Christensen, Louise N and Frias, Juan P and Jódar, Esteban and Kandler, Kristian and Rigas, Georgia and Wadden, Thomas A and Garvey, W Timothy},
  title = {Two‐year effect of semaglutide 2.4 mg on control of eating in adults with overweight/obesity: STEP 5},
  journal = {Obesity},
  year = {2023},
  volume = {31},
  number = {3},
  pages = {703--715},
  doi = {10.1002/oby.23673}
}
Kostenlos starten →